Valuation : Bayer AG

Market Cap 47.32B 54.92B 44.81B 40.61B 76.2B 5,247B 76.58B 532B 205B 2,670B 206B 202B 8,436B P/E 2026 *
21.8x
P/E 2027 * 15.7x
Enterprise Value 77.28B 89.69B 73.17B 66.32B 124B 8,568B 125B 869B 334B 4,359B 337B 329B 13,775B EV / Sales 2026 *
1.69x
EV / Sales 2027 * 1.58x
Free-Float
99.99%
Yield 2026 *
0.33%
Yield 2027 * 1.16%
1 day-1.09%
1 week-1.39%
Current month-1.77%
1 month+0.35%
3 months+33.10%
6 months+23.10%
Current year+30.15%
1 week 47.74
Extreme 47.74
49.68
1 month 47.22
Extreme 47.22
50.16
Current year 32.96
Extreme 32.96
53.92
1 year 25.78
Extreme 25.78
53.92
3 years 18.38
Extreme 18.378
53.92
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 60 01/06/2023
Director of Finance/CFO 57 01/06/2026
Chief Tech/Sci/R&D Officer 59 01/02/2021
Director TitleAgeSince
Director/Board Member 56 01/04/2012
Director/Board Member 61 01/04/2017
Chairman 68 28/04/2020
Date Insider Type Main position Quantity % Market Cap. Importance
3/18/26 A Buy

Director

1,900 0.0002%
3/18/26 A Buy

Executive/Senior Manager

13,000 0.0013%
3/18/26 A Buy

Director

1,500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.09%-1.39%+71.61%-4.93% 54.92B
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -0.76%-5.32%+27.03%+35.82% 355.97B
Weighted average by Cap. -0.51%-4.37%+31.59%+54.02%

Financials

2026 *2027 *
Net sales 45.78B 53.13B 43.34B 39.29B 73.7B 5,076B 74.08B 515B 198B 2,582B 200B 195B 8,160B 46.99B 54.53B 44.49B 40.33B 75.65B 5,210B 76.04B 528B 203B 2,651B 205B 200B 8,376B
Net income 2.14B 2.49B 2.03B 1.84B 3.45B 237B 3.47B 24.09B 9.26B 121B 9.34B 9.13B 382B 2.94B 3.41B 2.78B 2.52B 4.73B 326B 4.75B 33.04B 12.7B 166B 12.8B 12.52B 524B
Net Debt 29.95B 34.76B 28.36B 25.71B 48.23B 3,321B 48.47B 337B 130B 1,690B 131B 128B 5,339B 26.82B 31.13B 25.4B 23.02B 43.19B 2,974B 43.41B 302B 116B 1,513B 117B 114B 4,781B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,830
Date Price Change Volume
11/09/26 €48.17 -1.09% 2,438,272
10/09/26 €48.70 -1.14% 2,214,646
09/09/26 €49.26 -0.30% 2,105,631
08/09/26 €49.41 +1.44% 1,982,797
07/09/26 €48.71 -0.29% 959,766
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
48.17EUR
Average target price
58.22EUR
Spread / Average Target
+20.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!